Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 1, 2020
Hyperoxia improves autonomic function in individuals with long-duration type 1 diabetes and macroalbuminuria
J C Laursen, C S Hansen, M Bordino, et al.
Clinical Biochemistry
|
May 19, 2020
Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk
T Jespersen, L T Møllehave, B H Thuesen, et al.
Diabetes, Obesity & Metabolism
|
June 30, 2009
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
S S Lund, L Tarnow, A S Astrup, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 26, 2014
Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus
M J Pena, H J Lambers Heerspink, M E Hellemons, et al.
Diabetologia
|
October 23, 2012
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
S S Roscioni, D de Zeeuw, M E Hellemons, et al.
Diabetologia
|
April 27, 2013
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1
M G A van Eupen, M T Schram, H M Colhoun, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study
M Piazza, N M J Hanssen, F Persson, et al.
Diabetologia
|
August 17, 2010
A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
A Alkhalaf, S J L Bakker, H J G Bilo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 22, 2018
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes
N Tofte, M Lindhardt, K Adamova, et al.
Diabetes Research and Clinical Practice
|
January 24, 2025
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations
C Brock, H Andersen, A C Alibegovic, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 1, 2020
Hyperoxia improves autonomic function in individuals with long-duration type 1 diabetes and macroalbuminuria
J C Laursen, C S Hansen, M Bordino, et al.
Clinical Biochemistry
|
May 19, 2020
Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk
T Jespersen, L T Møllehave, B H Thuesen, et al.
Diabetes, Obesity & Metabolism
|
June 30, 2009
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
S S Lund, L Tarnow, A S Astrup, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 26, 2014
Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus
M J Pena, H J Lambers Heerspink, M E Hellemons, et al.
Diabetologia
|
October 23, 2012
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
S S Roscioni, D de Zeeuw, M E Hellemons, et al.
Diabetologia
|
April 27, 2013
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1
M G A van Eupen, M T Schram, H M Colhoun, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study
M Piazza, N M J Hanssen, F Persson, et al.
Diabetologia
|
August 17, 2010
A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
A Alkhalaf, S J L Bakker, H J G Bilo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 22, 2018
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes
N Tofte, M Lindhardt, K Adamova, et al.
Diabetes Research and Clinical Practice
|
January 24, 2025
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations
C Brock, H Andersen, A C Alibegovic, et al.
Page
of 14